U.S. Physical Therapy reaffirms guidance as clinic visits hit record 33.5 per day amid NYU Langone expansion.
U.S. Physical Therapy (USPH) kept its adjusted EBITDA forecast at $102M-$106M for Q2 2026, citing sustained demand and operational strength. The company reported all-time high clinic visits of 33.5 per day during the quarter, reinforcing confidence in its outlook.
Management noted elevated volumes across the business, with the NYU Langone rollout extending into Q3. Prior guidance was unchanged, aligning with earlier projections and market expectations for steady growth in the sector.
No immediate market reaction was disclosed in the earnings call summary.